Spark Investment Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Spark Investment Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-18,100	Closed	-$1.14M	–	315
2020 Q1	$1.14M	Sell	18,100 -6,300	-26%	-$566K	0.61%	44
2019 Q4	$3.02M	Sell	24,400 -45,300	-65%	-$4.06M	0.35%	88
2019 Q3	$4.63M	Hold	69,700	–	–	0.59%	51
2019 Q2	$5.55M	Sell	69,700 -25,100	-26%	-$2.25M	0.38%	76
2019 Q1	$10.6M	Buy	+94,800	New	+$10.4M	0.49%	51
2018 Q3	–	Sell	-62,900	Closed	-$5.28M	–	760
2018 Q2	$5.28M	Sell	62,900 -73,600	-54%	-$5.39M	0.31%	99
2018 Q1	$8.4M	Sell	136,500 -44,610	-25%	-$2.69M	0.54%	43
2017 Q4	$10.6M	Buy	181,110 +55,210	+44%	+$3.48M	0.57%	36
2017 Q3	$7.31M	Buy	+125,900	New	+$13.6M	0.39%	71
2013 Q4	–	Sell	-3,000	Closed	-$207K	–	718
2013 Q3	$207K	Buy	+3,000	New	+$148K	0.05%	440

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Spark Investment Management's ICPT Position: Q2 2020 in Review

Spark Investment Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2020, closing a stake of 18,100 shares — an estimated $1.14M sold.

Spark Investment Management first reported a position in ICPT in Q3 2013 and held it in 10 quarters. The position peaked at $10.6M in Q1 2019. 192 funds tracked by Wall St. Rank hold ICPT as of Q2 2020.

Spark Investment Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
Spark Investment Management sold 18,100 Intercept Pharmaceuticals, Inc. shares in Q2 2020, an estimated $1.14M.
Spark Investment Management first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2013 and held it in 10 quarters.
Spark Investment Management's Intercept Pharmaceuticals, Inc. position peaked at $10.6M in Q1 2019.
192 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2020.

Based on Spark Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.